-transparent.png){kind=logo}
BACKGROUND Recently, peptides derived from the heavy chain of HLA-B2702 have been shown to modulate immune responses. In this study, we examined the use of these peptides for immunosuppression in a pig to mouse islet xenograft model. METHODS Purified porcine islets were transplanted in autoimmune (non-obese diabetic) and non-autoimmune (streptozotocin-injected CBA or C57/Bl6) diabetic mice. Various dosing regimens of HLA-derived peptides with and without antilymphocyte therapy were administered to recipient mice. Graft rejection was determined by daily serum glucose determinations, and, at selected time points, grafts were removed to demonstrate function and provide immunohistochemical examination. RESULTS HLA-derived peptides were demonstrated to prolong graft survival in both pretransplant and posttransplant treatment regimens. This effect was increased with concomitant antilymphocyte therapy. CONCLUSIONS Further elucidation of the mechanism of action of these immunomodulatory peptides may help in the development of novel immunosuppressive protocols.
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
April 1982,
The American journal of pathology,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
September 1987,
Diabetes,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
June 2017,
Scientific reports,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
January 1997,
Transplantation proceedings,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
April 1981,
Diabetes,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
July 1980,
Science (New York, N.Y.),
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
September 1997,
Diabetes research and clinical practice,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
September 2000,
The Journal of surgical research,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
February 1991,
Transplantation proceedings,
E C Squiers, and
M Hodell, and
D Tice, and
R Buelow
March 2018,
Cell death & disease,
